HTE is going to be one of the drivers of medical and recreational cannabis education in Europe.
HTE was born as a needing to respond to necessity of enhance and connect the growing CBD sector in Europe.
- We are a B2B multi-brand distribution company and with our own brand GO Green.
- We count with two years of experience in the retail hemp spanish market.
- We curate brands and products throughout the European market.
- We have a wide range of products that meet optimal quality standards and European legal requirements.
- We need to anticipate the needs and trends of the global hemp market
‘We want to cover the offer of products and services necessary for the development of a booming sector’
We distribute European CBD and Cannabis brands, from oils to fertilizers. We try to introduce new brands in the local markets under advice.
You know all our brands?
You would like to have your own brand or a range of products. We deliver finished and packaged products.
Choose the option you want!
For producers, companies outside the world of cannabis and needs a large amount of product for manufacturing.
Tell us what you need and we will make it easy for you!
A model designed for the curation of products and brands
There are more and more brands and new products, but for us not all of them are valid, we are constantly among the best brands with very different products from each other.
Health – Cosmetic – Holistic – Wellness – Smoking – Consumables – Grow – Animals
What is CBD?
CBD, short for cannabidiol, is a chemical compound from the Cannabis sativa plant, which is also known as Hemp.
It’s a naturally occurring substance that’s used in products like oils and edibles to impart a feeling of relaxation and calm. Unlike its cousin, delta-9-tetrahydrocannabinol (THC), which is the major active ingredient in marijuana.
CBD is providing relief for anxiety, depression and post-traumatic stress disorder. It is also to help sleep.
CBD’s popularity is that it “nonpsychoactive,” and that consumers can reap health benefits from the sativa plant.
Approved by WHO
Initial evidence from animal and human studies (i.e. a controlled study in the New England Journal of Medicine and other reported individual cases) shows that its use could have some therapeutic value for seizures due to epilepsy and related conditions.
Learn more about Cannabidiol (compound of cannabis)
‘Who Expert Committee on Drug Dependence (ECDD) concluded that, in its pure state, cannabidiol does not appear to have abuse potential or cause harm’
‘Cannabidiol (CBD) is not considered a ‘narcotic drug’ under European law’
Not Drug by EU
European Commission has noted in a recent press briefing that cannabidiol should not be considered as a drug within the meaning of the United Nations Single Convention on Narcotic Drugs of 1961 and cannabidiol can be qualified as food, provided that the other conditions of the EU Food Safety Regulation are also met.
‘A global growth market, Europe second biggest’
Technological evolution has allowed cannabidiol to stop being the “ugly duckling” and become an industry that in 2020 generates almost $ 18 B and it is estimated that in 2025 it will be more than $ 38 B.
The market will be ACCELERATING growing at a CAGR of over.
The year-over-year growth rate for 2020 is estimated.
Of the growth will come from NORTH AMERICA.
Europe’s CBD Market
Projected annual CBD spending among EU member states
(2020 – 2025)
Projects, opportunities and conversations
Hemp Trade Europe
HTE Distribution SAS
6 Rue d’Armaillé, 75017 Paris, France
Calle Almirante 6, 28004 Madrid, Spain
Get in touch with us